Tag: Psychedelics Investing

Love Pharma's investment in Starton Therapeutics is primarily based upon "the company's interest in innovative drug delivery technology, such as ...

Love Pharma Delivers Letter to Shareholders

Love Pharma's investment in Starton Therapeutics is primarily based upon "the company's interest in innovative drug delivery technology, such as ...

Optimi Health To Launch Therapeutic Psilocybin Product In Partnership With Patient

Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), a homegrown, Canadian company licensed ...

Seelos Therapeutics to Participate in Two Upcoming Psychedelic Conferences

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company, researching, developing, and commercializing therapeutics to ...

Exploring the “Highs” of Marijuana & Psychedelic ETFs

September 8, 2022

This syndicated article was originally published by the Canadian ETF Market. The Investing News Network (INN) believes it may be ...

Optimi Health Initiates Agreement With SABI Mind For Therapeutic Supplies Of

August 27, 2022

The Company is scheduled to begin production and analytical testing of MDMA this October in its recently completed EU-GMP pharmaceutical ...

Awakn Life Sciences Provides a Business and Corporate Update

August 26, 2022

Phase III Trial to Cost approximately CA$3.75 million with Awakn's contribution expected to be approximately CA$1.25 million, Marks First Psychedelic ...

Another Public Company First: Silo Wellness Opens Jamaican Ecotourism Psilocybin

August 24, 2022

Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A) ("Silo Wellness" or the "Company"), a leading global psychedelics company, is ...

Albert Labs (CSE:ABRT) Closes $4.7m Private Placement; Begins Trading on the Canadian

August 21, 2022